Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials.

Suppr

超能文献

作者信息

Anderson J R, Cain K C, Gelber R D, Gelman R S

出版信息

Cancer Treat Rep. 1985 Oct;69(10):1139-46.

PMID:3899355

Abstract

摘要

相似文献

Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials.

Cancer Treat Rep. 1985 Oct;69(10):1139-46.

[Progress in breast cancer chemo-endocrine therapy from the survival standpoint].

Gan To Kagaku Ryoho. 1995 May;22(6):726-31.

A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.

Semin Oncol. 1984 Sep;11(3 Suppl 1):23-7.

[Adriamycin--breast cancer].

Gan To Kagaku Ryoho. 1996 Dec;23(14):1911-5.

Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support.

Bone Marrow Transplant. 1999 Aug;24(4):377-84. doi: 10.1038/sj.bmt.1701907.

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

J Clin Oncol. 2003 May 1;21(9):1819-24. doi: 10.1200/JCO.2003.05.119.

[Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].

Rinsho Ketsueki. 2009 Apr;50(4):276-81.

[Inflammatory carcinoma of the breast. Experience of 43 cases at the Instituto do Câncer Arnaldo Vieira de Carvalho].

Rev Paul Med. 1988 Jan-Feb;106(1):14-20.

Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B.

J Natl Cancer Inst Monogr. 1995(19):41-4.

Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.

J Natl Cancer Inst. 2004 Dec 15;96(24):1801-4. doi: 10.1093/jnci/djh347.

引用本文的文献

Suggestions on Using Machine Learning Models and Cautions for Analyzing Censored Time-To-Event Outcomes.

JCO Precis Oncol. 2024 May;8:e2400220. doi: 10.1200/PO.24.00220.

Reporting and methodological quality of survival analysis in articles published in Chinese oncology journals.

Medicine (Baltimore). 2017 Dec;96(50):e9204. doi: 10.1097/MD.0000000000009204.

Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.

BMC Cancer. 2016 Nov 7;16(1):856. doi: 10.1186/s12885-016-2868-y.

Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?

World J Urol. 2016 Jul;34(7):909-15. doi: 10.1007/s00345-015-1707-0. Epub 2015 Nov 19.

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

Ann Oncol. 2014 Oct;25(10):2036-2041. doi: 10.1093/annonc/mdu248. Epub 2014 Jul 9.

Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93.

Breast Cancer Res Treat. 2013 Nov;142(2):455-9. doi: 10.1007/s10549-013-2757-x. Epub 2013 Nov 7.

Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.

J Clin Oncol. 2010 Feb 20;28(6):949-54. doi: 10.1200/JCO.2009.25.4482. Epub 2010 Jan 19.

Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.

Cancer. 2010 Feb 15;116(4):852-62. doi: 10.1002/cncr.24845.

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.

Ann Oncol. 2009 Aug;20(8):1344-51. doi: 10.1093/annonc/mdp024. Epub 2009 May 25.

Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery.

Langenbecks Arch Surg. 2003 Sep;388(4):239-44. doi: 10.1007/s00423-003-0410-6. Epub 2003 Aug 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验